I think I just went through two bottles, Joanna says
Overall, the use of the GLP-1 receptor agonist-SGLT-2 inhibitor combination was associated with a 29% lower risk of major adverse cardiovascular events (7.6 v 10.7 per 1000 person years
But it does much more than that, everything from strengthening the immune system to processing fats in the liver
it slows down digestion, helping you feel full for longer
Manufacturers are in the process of making new GLP-1s that are easier to produce, store, and administer
Wang W, Volkow ND, Wang Q, Berger NA, Davis PB, Kaelber DC, Xu R